Edwards Lifesciences shares owned by Tributary Capital Management
Quarter-by-quarter ownership of Edwards Lifesciences (EW) shares owned by Tributary Capital Management
from 13F filings
Historical chart of Tributary Capital Management investment in Edwards Lifesciences
Tip: Access up to 7 years of quarterly data
All positions including Edwards Lifesciences held by Tributary Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Edwards Lifesciences by Tributary Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $665k | 7.0k | 95.56 |
| 2023-12-31 | $531k | 7.0k | 76.25 |
| 2023-09-30 | $496k | 7.2k | 69.28 |
| 2023-06-30 | $685k | 7.3k | 94.33 |
| 2023-03-31 | $386k | 4.7k | 82.73 |
| 2022-12-31 | $355k | 4.8k | 74.58 |
| 2022-09-30 | $402k | 4.9k | 82.72 |
| 2022-06-30 | $466k | 4.9k | 95.10 |
| 2022-03-31 | $589k | 5.0k | 117.80 |
| 2021-12-31 | $674k | 5.2k | 129.62 |
| 2021-09-30 | $614k | 5.4k | 113.18 |
| 2021-06-30 | $728k | 7.0k | 103.63 |
| 2021-03-31 | $588k | 7.0k | 83.70 |
| 2020-12-31 | $529k | 5.8k | 91.21 |
| 2020-09-30 | $475k | 6.0k | 79.83 |
| 2020-06-30 | $422k | 6.1k | 69.18 |
| 2020-03-31 | $402k | 2.1k | 188.73 |
| 2019-12-31 | $516k | 2.2k | 233.48 |
| 2019-09-30 | $2.5M | 11k | 219.89 |
| 2019-06-30 | $3.7M | 20k | 184.75 |
| 2019-03-31 | $3.9M | 21k | 191.32 |
| 2018-12-31 | $2.2M | 14k | 153.19 |
| 2018-09-30 | $2.7M | 15k | 174.09 |
| 2018-06-30 | $2.3M | 16k | 145.57 |
| 2018-03-31 | $2.2M | 16k | 139.50 |
| 2017-12-31 | $1.8M | 16k | 112.68 |
| 2017-09-30 | $2.4M | 22k | 109.32 |
| 2017-06-30 | $2.1M | 17k | 118.22 |
| 2017-03-31 | $1.8M | 19k | 94.07 |
| 2016-12-31 | $2.0M | 22k | 93.70 |
| 2016-09-30 | $2.7M | 23k | 120.58 |
| 2016-06-30 | $2.7M | 27k | 99.74 |
| 2016-03-31 | $2.5M | 28k | 88.20 |
| 2015-12-31 | $2.2M | 28k | 78.99 |
| 2015-09-30 | $2.2M | 15k | 142.14 |
| 2015-06-30 | $570k | 4.0k | 142.50 |
More positions owned by Tributary Capital Management
View all positions for Tributary Capital Management